Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan

Background: Although tolvaptan, an electrolyte-free water diuretic for congestive heart failure (HF), is reported to have no effect on long-term mortality or HF-related morbidity, there may exist some subgroups of patients who may receive beneficial effect of tolvaptan. The purpose of this study was...

Full description

Bibliographic Details
Main Authors: Kensuke Fujioka, Sumio Mizuno, Taro Ichise, Takao Matsui, Hiroaki Hirase, Masato Yamaguchi, Takahiko Aoyama, Masakazu Yamagishi, Noboru Fujino, Masa-aki Kawashiri, Kenshi Hayashi
Format: Article
Language:English
Published: SAGE Publishing 2019-01-01
Series:Therapeutic Advances in Cardiovascular Disease
Online Access:https://doi.org/10.1177/1753944718819064